Equities

Acme United Corp

Acme United Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)42.23
  • Today's Change0.45 / 1.08%
  • Shares traded2.16k
  • 1 Year change+14.66%
  • Beta0.6587
Data delayed at least 15 minutes, as of Nov 13 2024 15:50 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Acme United Corporation is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. It markets and sells through two main product categories: first aid and medical and cutting and sharpening. The first aid and medical category includes first aid and safety products, such as First Aid Only, PhysiciansCare, Pac-Kit, Spill Magic, First Aid Central, Med-Nap and Safety Made brands. Its cutting and sharpening categories include school, home and office products (Westcott brand). Brands under hardware, industrial and sporting goods products are Clauss and DMT. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, and sharpening tools. It is also a supplier of tactical, trauma and emergency response products. It sells its products to mass market and e-commerce retailers, wholesale, contract and retail stationery distributors, and hardware chains.

  • Revenue in USD (TTM)190.49m
  • Net income in USD19.52m
  • Incorporated1882
  • Employees645.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sensus Healthcare Inc36.37m6.65m117.18m35.0017.562.2217.073.220.40720.40722.233.230.66011.102.651,039,057.0012.0610.2913.2512.1460.2362.8518.2715.298.20--0.00---45.20-1.58-98.00---23.16--
TELA Bio Inc64.74m-42.11m122.50m227.00--26.74--1.89-1.71-1.712.640.11630.83761.487.62285,215.80-54.48-52.00-66.54-60.9568.6165.32-65.04-107.652.52-8.690.9343--41.1347.85-5.35---17.12--
KORU Medical Systems Inc30.82m-11.76m136.19m82.00--7.28--4.42-0.2574-0.25740.67420.40820.97372.946.50375,817.30-37.15-17.60-43.48-20.2962.4959.44-38.16-21.703.27--0.0195--2.2310.44-58.65--11.10--
EUDA Health Holdings Ltd3.81m-17.99m140.16m106.00------36.77-0.4821-0.44510.1487-0.16851.86--7.2135,957.55-876.41------22.05---472.08-----43.68-----1.54--66.17------
Myomo Inc25.24m-8.38m150.93m101.00--16.24--5.98-0.2294-0.22940.68470.30721.513.118.08249,892.40-50.25-81.78-81.40-115.2770.0368.50-33.22-85.761.62--0.00--23.7051.0924.00--2.82--
Acme United Corp190.49m19.52m156.32m645.008.461.457.250.82064.944.9446.9028.771.182.095.84295,331.7012.137.0914.258.2939.3735.7210.255.501.917.060.233718.81-1.276.88486.3131.089.024.84
Cibus Inc4.15m-445.40m156.87m183.00--1.30--37.77-22.43-22.430.19874.090.0071--4.7522,693.99-91.76-86.28-109.53-96.45-----12,860.99-792.07---3.230.0061--1,057.3350.41-1,484.44--18.53--
Akoya Biosciences Inc93.22m-60.35m157.90m330.00--7.09--1.69-1.22-1.221.890.44980.56051.936.34282,472.70-36.29---45.98--57.57---64.74--1.98-8.000.7755--29.09--10.36------
Alpha Tau Medical Ltd0.00-27.63m158.03m121.00--2.14-----0.3966-0.39660.001.060.00----0.00-26.66---28.28--------------0.0681------13.64------
Pro-Dex Inc56.80m5.21m161.50m148.0032.385.2925.282.841.531.5316.349.361.092.484.64383,770.3010.0312.3312.3515.3028.2531.269.1712.131.945.310.3040.0016.8314.66-69.93-12.47-6.80--
Senseonics Holdings Inc22.21m-80.33m186.68m132.00------8.41-0.1302-0.13020.0360.03750.17743.795.94168,219.70-64.16-73.65-81.31-106.97-10.49-40.41-361.77-649.862.38-27.980.7244--36.623.43-142.49---18.76--
Nevro Corp419.15m-69.31m188.65m1.22k--0.6923--0.4501-1.89-1.8911.407.310.72441.106.01344,976.10-11.98-13.64-14.11-16.6868.0268.54-16.54-20.673.76-8.210.4482--4.631.88-3,172.74--0.9012--
SANUWAVE Health Inc24.90m-3.43m191.17m31.00------7.68-3.55-3.558.17-12.561.243.908.34803,064.50-17.07-136.54----71.5769.13-13.79-189.600.09990.1199----21.8461.61-150.72------
Stereotaxis Inc25.14m-22.89m191.32m122.00--17.70--7.61-0.2717-0.27170.29880.19150.52681.403.82206,090.20-45.19-25.02-69.91-34.1256.1467.57-85.79-41.900.9557-------4.89-1.82-12.33--6.63--
Accuray Inc444.20m-20.08m192.08m987.00--4.24--0.4324-0.2032-0.20324.480.45030.93532.015.25450,054.70-4.23-1.37-7.35-2.3331.0936.43-4.52-1.550.8655-0.09360.7901---0.23551.29-67.51---3.54--
Data as of Nov 13 2024. Currency figures normalised to Acme United Corp's reporting currency: US Dollar USD

Institutional shareholders

53.78%Per cent of shares held by top holders
HolderShares% Held
The Capital Management Corp.as of 30 Sep 2024553.84k14.99%
North Star Investment Management Corp.as of 30 Sep 2024302.73k8.19%
Mink Brook Asset Management LLCas of 15 Aug 2024204.87k5.54%
Dimensional Fund Advisors LPas of 30 Sep 2024170.45k4.61%
Polar Asset Management Partners, Inc.as of 30 Jun 2024159.75k4.32%
The Vanguard Group, Inc.as of 30 Jun 2024144.65k3.92%
Royce & Associates LPas of 30 Sep 2024135.71k3.67%
Renaissance Technologies LLCas of 30 Jun 2024130.41k3.53%
Bard Associates, Inc.as of 30 Sep 2024119.50k3.23%
Acadian Asset Management LLCas of 30 Jun 202465.22k1.77%
More ▼
Data from 30 Jun 2024 - 05 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.